Guanidinoacetate methyltransferase (GAMT) deficiency:: non-invasive enzymatic diagnosis of a newly recognized inborn error of metabolism

被引:42
作者
Ilas, J [1 ]
Mühl, A [1 ]
Stöckler-Ipsiroglu, S [1 ]
机构
[1] Univ Vienna, Dept Pediat, Natl Newborn Screening Lab, Vienna, Austria
关键词
creatine deficiency; guanidinoacetate; fibroblasts; lymphoblasts; amniotic cells;
D O I
10.1016/S0009-8981(99)00182-5
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Guanidinoacetate methyltransferase deficiency is a newly recognized inborn error of creatine biosynthesis, Manifestation of neurologic symptoms occurs in infancy and is partly reversible upon oral substitution of creatine. In the first two index patients, enzymatic diagnosis was established in a liver biopsy, and the underlying molecular defect in the GAMT gene has been identified. In order to provide non-invasive biochemical diagnosis, we have developed an enzyme assay based on the formation of radiolabeled creatine from C-14 guanidinoacetate and S-adenosylmethionine in concentrated and dialyzed extracts from cultivated skin fibroblasts, Epstein-Barr virus transformed lymphoblasts, and cultivated amniotic cells. Cells were investigated from controls, from 1 index patient with proven GAMT deficiency and from 3 additional patients with clinical and biochemical signs of GAMT deficiency. Separation of C-14 guanidinoacetate from C-14 creatine in the reaction mixture was accomplished by HPLC on Hypersil ODS column and radioactivity was determined in fractions according to respective UV signals, GAMT activities in control fibroblasts (n = 7), lymphoblasts (n = 8) and in amniotic cells (n = 2) were 0.38-0.56, 0.61-0.84 and 0.38-0.56 nmol/h/mg protein. Apparent Km values were 9.5-14.8 mu M for guanidinoacetate and 68-78 mu M for S-adenosylmethionine In the index patient and in the three additional patients at risk, GAMT activity was <0.1 nmol/h/mg protein. The assay described here allows non-invasive diagnosis of GAMT deficiency in patients at risk, (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:179 / 188
页数:10
相关论文
共 13 条
[1]   GUANIDINOACETATE METHYLTRANSFERASE ACTIVITY IN TISSUES AND CULTURED-CELLS [J].
DALY, MM .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1985, 236 (02) :576-584
[2]   Guanidinoacetate methyltransferase deficiency: New clinical features [J].
Ganesan, V ;
Johnson, A ;
Connelly, A ;
Eckhardt, S ;
Surtees, RAH .
PEDIATRIC NEUROLOGY, 1997, 17 (02) :155-157
[3]  
IM YS, 1979, J BIOL CHEM, V254, P1047
[4]   RADIOACTIVE ASSAY FOR GUANIDOACETATE METHYLTRANSFERASE [J].
IM, YS ;
CANTONI, GL ;
CHIANG, PK .
ANALYTICAL BIOCHEMISTRY, 1979, 95 (01) :87-88
[5]   GUANIDOACETATE METHYLTRANSFERASE FROM RAT-LIVER - PURIFICATION, PROPERTIES, AND EVIDENCE FOR THE INVOLVEMENT OF SULFHYDRYL-GROUPS FOR ACTIVITY [J].
OGAWA, H ;
ISHIGURO, Y ;
FUJIOKA, M .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1983, 226 (01) :265-275
[6]   Creatine deficiency syndrome caused by guanidinoacetate methyltransferase deficiency: Diagnostic tools for a new inborn error of metabolism [J].
Schulze, A ;
Hess, T ;
Wevers, R ;
Mayatepek, E ;
Bachert, P ;
Marescau, B ;
Knopp, MV ;
DeDeyn, PP ;
Bremer, HJ ;
Rating, D .
JOURNAL OF PEDIATRICS, 1997, 131 (04) :626-631
[7]   Guanidino compounds in guanidinoacetate methyltransferase deficiency, a new inborn error of creatine synthesis [J].
Stockler, S ;
Marescau, B ;
DeDeyn, PP ;
Trijbels, JMF ;
Hanefeld, F .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1997, 46 (10) :1189-1193
[8]   Creatine replacement therapy in guanidinoacetate methyltransferase deficiency, a novel inborn error of metabolism [J].
Stockler, S ;
Hanefeld, F ;
Frahm, J .
LANCET, 1996, 348 (9030) :789-790
[9]  
STOCKLER S, 1994, PEDIATR RES, V36, P409
[10]  
Stockler S, 1996, AM J HUM GENET, V58, P914